Patents by Inventor Sally Louise MARSH

Sally Louise MARSH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240122909
    Abstract: The present invention relates to treatments of hereditary angioedema (HAE). In particular, the present invention provides on-demand treatments of hereditary angioedema (HAE) by orally administering a plasma kallikrein inhibitor to a patient in need thereof on-demand.
    Type: Application
    Filed: February 9, 2022
    Publication date: April 18, 2024
    Inventors: Edward Paul FEENER, Sally Louise MARSH, Andreas MAETZEL, Michael David SMITH, Christopher Martyn YEA
  • Publication number: 20230381162
    Abstract: The present invention relates to treatments of bradykinin-mediated angioedema. In particular, the present invention provides on-demand treatments of bradykinin-mediated angioedema by orally administering a plasma kallikrein inhibitor to a patient in need thereof on-demand as an oral dosage form particularly suitable for patients who may struggle to swallow tablets.
    Type: Application
    Filed: October 22, 2021
    Publication date: November 30, 2023
    Inventors: John Alexander COOPER, Edward Paul FEENER, Andreas MAETZEL, Sally Louise MARSH, Michael David SMITH, Christopher Martyn YEA
  • Publication number: 20220298138
    Abstract: The present invention provides compounds of formula (I): Formula (I) compositions comprising such compounds; the use of such compounds in therapy; and methods of treating patients with such compounds; wherein A, Y, n, R1, R2A, R2B, R3 and *1 are as defined herein.
    Type: Application
    Filed: August 21, 2019
    Publication date: September 22, 2022
    Inventors: Rebecca Louise DAVIE, Hannah Joy EDWARDS, David Michael EVANS, Simon Teanby HODGSON, Sally Louise MARSH, Alessandro MAZZACANI, David Philip ROOKER, Michael John STOCKS, Andrew Peter CRIDLAND, Emanuela GANCIA, Julie Nicole HAMBLIN, Paul Stuart HINCHLIFFE, Stefano LEVANTO, Terence Aaron PANCHAL, Iain Robert MILLER
  • Publication number: 20220226293
    Abstract: The present invention relates to treatments of angioedema, and specifically bradykinin-mediated angioedema non-hereditary (BK-AEnH). In particular, the present invention provides on-demand treatments of bradykinin-mediated angioedema non-hereditary (BK-AEnH) by orally administering a plasma kallikrein inhibitor to a patient in need thereof on-demand. Regular (or continuous) treatments of BK-AEnH are also provided.
    Type: Application
    Filed: June 15, 2020
    Publication date: July 21, 2022
    Inventors: Edward Paul FEENER, Sally Louise MARSH, Andreas MAETZEL, Michael David SMITH, Christopher Martyn YEA
  • Publication number: 20220218680
    Abstract: The present invention relates to treatments of hereditary angioedema (HAE). In particular, the present invention provides on-demand treatments of hereditary angioedema (HAE) by orally administering a plasma kallikrein inhibitor to a patient in need thereof on-demand. Regular (or continuous) treatments of HAE are also provided.
    Type: Application
    Filed: June 15, 2020
    Publication date: July 14, 2022
    Inventors: Edward Paul FEENER, Sally Louise MARSH, Andreas MAETZEL, Michael David SMITH, Christopher Martyn YEA
  • Publication number: 20200261383
    Abstract: The invention relates to aqueous solution pharmaceutical compositions comprising at least one non-ionic tonicity agent, at least one buffer and an active ingredient, wherein said active ingredient is a compound of formula I, wherein R1-R9 are defined herein; processes for preparing these compositions and their use in medicine, especially their use in the treatment of ocular diseases.
    Type: Application
    Filed: August 13, 2018
    Publication date: August 20, 2020
    Inventors: Gary COOK, Sally Louise MARSH, Stephen John PETHEN, Michael Bryan ROE, Christopher Martyn YEA